United States· US:66869-404_f558f406-3b8e-4a4b-a817-2fb2e624c79c

Livalo

A pitavastatin product containing pitavastatin calcium, registered in United States by Kowa Pharmaceuticals America, Inc.. The same ATC class is registered in 12 of our 19 countries.

ATC C10AA08Orange BookUS label

Checked against FDA National Drug Code directory (United States) on September 12, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about pitavastatin calciumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Pitavastatin is registered in 12 of 19 countries.

Countries holding a registration under ATC C10AA08 (pitavastatin), each read from that country’s own register.

This record: United States, from FDA National Drug Code directory (United States)
9 of them publish a price we can compare per daily dose

Search pitavastatin products by name

Pitavastatin · ATC C10AA08

12 / 19 countries

Belgiumprice
Czechiaprice
Finlandprice
Franceprice
Germany
Ireland
Netherlands
Norwayprice
Polandprice
Spainprice
Switzerlandprice
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of pitavastatin costs, country by country.

Normalised to the WHO defined daily dose (2 mg), the median price runs from $0.43 in Spain to $3.35 in United States — a ×7.7 gap.

United States: $3.35 per daily dose (median across products in the class)
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Pitavastatin · price per daily dose (2 mg)

USD · FX 28 Sept 2026

US United States$3.35 (acquisition cost)
CH Switzerland$1.57
ES Spain$0.43

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)

Active substance: pitavastatin calcium
Manufacturer: Kowa Pharmaceuticals America, Inc.
Country: United States (US)
ATC code: C10AA08
ATC class: Pitavastatin
Defined daily dose: 2 mg, O
Reimbursed: Not published by this register
Source register: FDA National Drug Code directory (United States)
Last checked: September 12, 2026

Packs & prices · 1

ndc11
6686940490
90 TABLET, FILM COATED in 1 BOTTLE, DISPENSING (66869-404-90)

Regulatory notes

UNII (FDA substance ID)

IYD54XEG3W

PITAVASTATIN CALCIUM

RxCUI 861640

Orange Book

N022363

ABABAB

DailyMed SPL labels

1 version tracked

Interactions

116 interactions on record for pitavastatin.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check pitavastatin against other medicines How interaction checks work

Pitavastatin · interactions on record

116 records

7 severe
103 moderate
2 minor

Most severe, free to view

ErythromycinJ01FA01severe
LeflunomidL04AA13severe
TeriflunomidL04AA31severe
CiclosporinL04AD01severe

4 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pitavastatin in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pitavastatin products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

Austria · Trolise
Bulgaria · Липоканте, Питавиа
Cyprus · Vaspit
Czechia · Pitilox
Germany · Livazo, Pitavastatin
Spain · Alipza, Lipix
France · Lippiza, Trolise
Greece · Fiarat, Livazo
Hungary · Pitilox
Ireland · Livazo
Italy · Livazo
Lithuania · Pitipix
Malta · Vaspit
Netherlands · Livazo
Norway · Livazo
Poland · Livazo, Pitamet
Portugal · Alipza, Livazo
Romania · Pitipix
Slovenia · Pitipix
Slovakia · Pitipix

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/f7c0c75b-59be-49ff-b5e8-82f389483fd0
GET /v1/drugs/f7c0c75b-59be-49ff-b5e8-82f389483fd0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unii": {
    "unii": "IYD54XEG3W",
    "rxcui": "861640",
    "inchikey": "RHGYHLPFVJEAOC-FFNUKLMVSA-L",
    "display_name": "PITAVASTATIN CALCIUM",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "ORAL",
  "livertox": {
    "summary": null,
    "livertox_id": null,
    "hepatotoxicity_score": 4
  },
  "spl_meta": {
    "44dcbf97-99ec-427c-ba50-207e0069d6d2": {
      "match": "brand_token",
      "title": "LIVALO (PITAVASTATIN CALCIUM) TABLET, FILM COATED [KOWA PHARMACEUTICALS AMERICA, INC.]",
      "spl_version": "11",
      "published_date": "2026-02-10"
    }
  },
  "productid": "66869-404_f558f406-3b8e-4a4b-a817-2fb2e624c79c",
  "productndc": "66869-404",
  "dosage_form": "TABLET, FILM COATED",
  "orange_book": {
    "appl_no": "022363",
    "products": [
      {
        "rs": false,
        "rld": true,
        "te_code": "AB",
        "strength": "EQ 1MG BASE",
        "product_no": "001",
        "approval_date": "Aug 3, 2009"
      },
      {
        "rs": false,
        "rld": true,
        "te_code": "AB",
        "strength": "EQ 2MG BASE",
        "product_no": "002",
        "approval_date": "Aug 3, 2009"
      },
      {
        "rs": true,
        "rld": true,
        "te_code": "AB",
        "strength": "EQ 4MG BASE",
        "product_no": "003",
        "approval_date": "Aug 3, 2009"
      }
    ],
    "appl_type": "N"
  },
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "PITAVASTATIN CALCIUM",
  "proprietary_name": "Livalo",
  "active_ingred_unit": "mg/1",
  "application_number": "NDA022363",
  "marketing_category": "NDA",
  "nonproprietary_name": "pitavastatin calcium",
  "start_marketing_date": "20190516",
  "active_numerator_strength": "4.18"
}

API reference MCP server Plans

See everything about pitavastatin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console